JN
Jupiter NeurosciencesClinical-stage biotech developing JOTROL, an enhanced resveratrol formulation for Parkinson's disease and other CNS/neuroinflammation disorders, alongside its Nugevia longevity supplement line.
2 Pulse stories
OB
Ollin BiosciencesClinical-stage biopharmaceutical company developing next-generation therapies for vision-threatening eye diseases, led by its bispecific antibody OLN324 for DME and wet AMD.
2 Pulse stories
Total Raised
$430M
Jupiter NeurosciencesOllin Biosciences
Last ValuationNot disclosed
Biotech
Sector
Biotech
2015
Founded
2023
Jupiter, Florida
HQ
Chicago, Illinois
Public (JUNS)
Status
Private
Jupiter Neurosciences investors
No investors on record.
Ollin Biosciences investors
ARCH Venture PartnersTCGXa16z Bio+HealthMubadala CapitalPolaris PartnersRA Capital ManagementCPP InvestmentsBlackstone Multi-Asset Investing
Data from Value Add Pulse coverage and company research — see the full threads for Jupiter Neurosciences and Ollin Biosciences.